Embrex Poultry Health

Embrex is a leading provider of automated in ovo injection technology and biological delivery systems for the global poultry industry. The company's flagship platform, the Inovoject system, revolutionized poultry production by allowing vaccines to be administered to chicks while they are still in the egg, significantly improving efficiency and early-life immunity. Originally founded in 1985 and based in North Carolina's Research Triangle Park, Embrex was acquired by Pfizer Animal Health in 2006, which later became the independent company Zoetis. Today, Embrex operates as a key brand within Zoetis, offering a suite of products including egg-scanning technology and high-throughput vaccination hardware. Their solutions are used by major poultry producers worldwide to manage diseases such as Marek's disease and Coccidiosis.